drugset / Trial / NCT00669591
A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to determine the overall response to a combination of bavituximab and docetaxel in patients with advanced breast cancer
Timeline
- Start
- 2008-01
- Primary completion
- 2010-06
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bavituximab | Monoclonal antibody | 3 mg/kg | — |
| Background | Docetaxel | Small molecule | — | — |